BACKGROUND: Infection with HIV-1 is characterized by genetic diversity such that specific viral subtypes are predominant in specific geographical areas. The genetic variation in HIV-1 pol and env genes is responsible for rapid development of resistance to current drugs. This variation has influenced disease progression among the infected and necessitated the search for alternative drugs with novel targets. Though successfully used in developed countries, these novel drugs are still limited in resource-poor countries. The aim of this study was to determine HIV-1 subtypes, recombination, dual infections and viral tropism of HIV-1 among Kenyan patients prior to widespread use of antiretroviral drugs. METHODS: Remnant blood samples from consenting sexually transmitted infection (STI) patients in Nairobi were collected between February and May 2001 and stored. Polymerase chain reaction and cloning of portions of HIV-1 gag, pol and env genes was carried out followed by automated DNA sequencing. RESULTS: Twenty HIV-1 positive samples (from 11 females and 9 males) were analyzed. The average age of males (32.5 years) and females (26.5 years) was significantly different (p value < 0.0001). Phylogenetic analysis revealed that 90% (18/20) were concordant HIV-1 subtypes: 12 were subtype A1; 2, A2; 3, D and 1, C. Two samples (10%) were discordant showing different subtypes in the three regions. Of 19 samples checked for co-receptor usage, 14 (73.7%) were chemokine co-receptor 5 (CCR5) variants while three (15.8%) were CXCR4 variants. Two had dual/mixed co-receptor use with X4 variants being minor population. CONCLUSION: HIV-1 subtype A accounted for majority of the infections. Though perceived to be a high risk population, the prevalence of recombination in this sample was low with no dual infections detected. Genotypic co-receptor analysis showed that most patients harbored viruses that are predicted to use CCR5.
BACKGROUND:Infection with HIV-1 is characterized by genetic diversity such that specific viral subtypes are predominant in specific geographical areas. The genetic variation in HIV-1pol and env genes is responsible for rapid development of resistance to current drugs. This variation has influenced disease progression among the infected and necessitated the search for alternative drugs with novel targets. Though successfully used in developed countries, these novel drugs are still limited in resource-poor countries. The aim of this study was to determine HIV-1 subtypes, recombination, dual infections and viral tropism of HIV-1 among Kenyan patients prior to widespread use of antiretroviral drugs. METHODS: Remnant blood samples from consenting sexually transmitted infection (STI) patients in Nairobi were collected between February and May 2001 and stored. Polymerase chain reaction and cloning of portions of HIV-1gag, pol and env genes was carried out followed by automated DNA sequencing. RESULTS: Twenty HIV-1 positive samples (from 11 females and 9 males) were analyzed. The average age of males (32.5 years) and females (26.5 years) was significantly different (p value < 0.0001). Phylogenetic analysis revealed that 90% (18/20) were concordant HIV-1 subtypes: 12 were subtype A1; 2, A2; 3, D and 1, C. Two samples (10%) were discordant showing different subtypes in the three regions. Of 19 samples checked for co-receptor usage, 14 (73.7%) were chemokine co-receptor 5 (CCR5) variants while three (15.8%) were CXCR4 variants. Two had dual/mixed co-receptor use with X4 variants being minor population. CONCLUSION:HIV-1 subtype A accounted for majority of the infections. Though perceived to be a high risk population, the prevalence of recombination in this sample was low with no dual infections detected. Genotypic co-receptor analysis showed that most patients harbored viruses that are predicted to use CCR5.
Authors: Chih-chin Huang; Min Tang; Mei-Yun Zhang; Shahzad Majeed; Elizabeth Montabana; Robyn L Stanfield; Dimiter S Dimitrov; Bette Korber; Joseph Sodroski; Ian A Wilson; Richard Wyatt; Peter D Kwong Journal: Science Date: 2005-11-11 Impact factor: 47.728
Authors: Zabrina L Brumme; James Goodrich; Howard B Mayer; Chanson J Brumme; Bethany M Henrick; Brian Wynhoven; Jerome J Asselin; Peter K Cheung; Robert S Hogg; Julio S G Montaner; P Richard Harrigan Journal: J Infect Dis Date: 2005-06-23 Impact factor: 5.226
Authors: M Poss; J Gosink; E Thomas; J K Kreiss; J Ndinya-Achola; K Mandaliya; J Bwayo; J Overbaugh Journal: AIDS Res Hum Retroviruses Date: 1997-04-10 Impact factor: 2.205
Authors: W Janssens; L Heyndrickx; K Fransen; M Temmerman; A Leonaers; T Ivens; J Motte; P Piot; G Van der Groen Journal: AIDS Res Hum Retroviruses Date: 1994-11 Impact factor: 2.205
Authors: F Simon; P Mauclère; P Roques; I Loussert-Ajaka; M C Müller-Trutwin; S Saragosti; M C Georges-Courbot; F Barré-Sinoussi; F Brun-Vézinet Journal: Nat Med Date: 1998-09 Impact factor: 53.440
Authors: P J Kanki; D J Hamel; J L Sankalé; C c Hsieh; I Thior; F Barin; S A Woodcock; A Guèye-Ndiaye; E Zhang; M Montano; T Siby; R Marlink; I NDoye; M E Essex; S MBoup Journal: J Infect Dis Date: 1999-01 Impact factor: 5.226
Authors: Michael Saag; James Goodrich; Gerd Fätkenheuer; Bonaventura Clotet; Nathan Clumeck; John Sullivan; Mike Westby; Elna van der Ryst; Howard Mayer Journal: J Infect Dis Date: 2009-06-01 Impact factor: 5.226
Authors: Anthony Kebira Nyamache; Anne W T Muigai; Zipporah Ng'ang'a; Samoel A Khamadi Journal: AIDS Res Hum Retroviruses Date: 2013-05-21 Impact factor: 2.205
Authors: Rose C Kitawi; Carol W Hunja; Rashid Aman; Bernhards R Ogutu; Anne W T Muigai; Gilbert O Kokwaro; Washingtone Ochieng Journal: Virol J Date: 2017-02-14 Impact factor: 4.099
Authors: Nuno R Faria; Nicole Vidal; José Lourenco; Jayna Raghwani; Kim C E Sigaloff; Andy J Tatem; David A M van de Vijver; Andrea-Clemencia Pineda-Peña; Rebecca Rose; Carole L Wallis; Steve Ahuka-Mundeke; Jean-Jacques Muyembe-Tamfum; Jérémie Muwonga; Marc A Suchard; Tobias F Rinke de Wit; Raph L Hamers; Nicaise Ndembi; Guy Baele; Martine Peeters; Oliver G Pybus; Philippe Lemey; Simon Dellicour Journal: PLoS Pathog Date: 2019-12-06 Impact factor: 6.823
Authors: Veronica Wambui; Michael Kiptoo; Joyceline Kinyua; Irene Odera; Edward Muge; Peter Muiruri; Raphael Lihana; Peter Kinyanjui; Elijah M Songok Journal: AIDS Res Ther Date: 2012-07-28 Impact factor: 2.250